. Author manuscript; available in PMC: 2021 Apr 1.

Published in final edited form as: Alzheimer Dis Assoc Disord. 2020 Apr-Jun;34(2):118–121. doi: 10.1097/WAD.0000000000000366

TABLE 4.

Cross-sectional Multivariate Associations Between Prostate Cancer, ADT use and Odds of Mild of Cognitive Impairment (N=2,385)

Variable	Odds Ratio	Low 95% CI	High 95% CI
Age (y) at first visit	1.06	1.04	1.08
Education (y)	0.88	0.84	0.91
Charlson index	1.09	1.05	1.14
BAI	1.08	1.05	1.11
BDI (>13)	1.53	1.02	2.29
Any APOE4	1.28	0.98	1.67
Diabetes mellitus	0.85	0.62	1.16
Hypertension	1.19	0.87	1.63
Prostate cancer	0.73	0.51	1.04
ADT exposure	0.95	0.20	4.41

ADT indicates androgen deprivation therapy; BAI, Beck Anxiety Index; BDI, Beck Depression Inventory.